HOW WE'RE TACKLING LIVER DISEASE
Learn about the approaches we’re taking to develop new classes of medicines.
PRESS RELEASES
August 8, 2018
Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases
